Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene

Psychiatry Research

Volumn 118, Issue 1, 2003, Pages 25-31

  Inada, Yasushi ^a   Yoneda, Hiroshi ^a   Koh, Jun ^a   Sakai, Jun ^a   Himei, Akio ^a   Kinoshita, Yoko ^a   Akabame, Kazuyo ^a   Hiraoka, Yayoi ^a   Sakai, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Agoraphobia; Genetic study; Panic disorder; Serotonin (5 hydroxytryptamine, 5HT)

Indexed keywords

DNA; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR;

ADULT; AGORAPHOBIA; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; NEUROTRANSMISSION; PANIC; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROTONINERGIC SYSTEM;

EID: 0037959870     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(03)00064-7     Document Type: Article

References (37)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed:1994;American Psychiatric Association, Washington, DC.
2. Arranz M., Collier D., Sodhi M., Ball D., Roberts G., Price J., Sham P., Kerwin R. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet. 346:1995;281-282.
3. Bell C.J., Nutt D.J. Serotonin and panic. British Journal of Psychiatry. 172:1998;465-471.
4. Burnet P.W., Harrison P.J. Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet. 346:1995;909.
5. Cloninger C. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatric Developments. 3:1986;167-226.
6. Collier D.A., Arranz M.J., Li T., Mupita D., Brown N., Treasure J. Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. Lancet. 350:1997;412.
7. Crowe R.R., Noyes R., Pauls D.L., Slymen D. A family study of panic disorder. Archives of General Psychiatry. 40:1983;1065-1069.
8. Deakin J.F.W., Guimaraes F.S., Wang S., Hensman R. Experimental tests of the 5-HT receptor imbalance theory of affective disturbance. Sandler M., Coppen A., Harnett S. 5-Hydroxytryptamine in Psychiatry, A Spectrum of Ideas. 1991;143-156 Oxford University Press, Oxford.
9. Deckert J., Nothen M.M., Franke P., Delmo C., Fritze J., Knapp M., Maier W., Beckmann H., Propping P. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Molecular Psychiatry. 3:1998;81-85.
10. Den Boer J.A., Westenberg H.G. Serotonin function in panic disorder: a double-blind placebo-controlled study with fluvoxamine and ritanserin. Psychopharmacology. 102:1990;85-94.
11. Eaton W.W., Kessler R.C., Wittchen H.U., Magee W.J. Panic and panic disorder in the United States. American Journal of Psychiatry. 151:1994;413-420.
12. Fehr C., Grintschuk N., Szegedi A., Anghelescu I., Klawe C., Singer P., Hiemke C., Dahmen N. The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy. Psychiatry Research. 97:2000a;1-10.
13. Fehr C., Szegedi A., Anghelescu I., Klawe C., Hiemke C., Dahmen N. Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study. Psychiatric Genetics. 10:2000b;59-65.
14. Graeff F.G., Guimaraes F.S., De Andrade T.G., Deakin J.F. Role of 5-HT in stress, anxiety, and depression. Pharmacology, Biochemistry and Behavior. 54:1996;129-141.
15. Gutierrez B., Arranz M., Fananas L., Valles V., Guillamat R., van Os J., Collier D. 5HT2A receptor gene and bipolar affective disorder. Lancet. 346:1995;969.
16. Hamilton S.P., Heiman G.A., Haghighi F., Mick S., Klein D.F., Hodge S.E., Weissman M.M., Fyer A.J., Knowles J.A. Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. Psychiatric Genetics. 9:1999;1-6.
17. Hensman R., Guimaraes F.S., Wang M., Deakin J.F. Effects of ritanserin on aversive classical conditioning in humans. Psychopharmacology (Berlin). 104:1991;220-224.
18. Hsieh C.L., Bowcock A.M., Farrer L.A., Hebert J.M., Huang K.N., Cavalli-Sforza L.L., Julius D., Francke U. The serotonin receptor subtype-2 locus HTR2 is on human chromosome 13 near genes for esterase D and retinoblastoma and on mouse chromosome 14. Somatic Cell and Molecular Genetics. 16:1990;567-574.
19. Inayama Y., Yoneda H., Sakai T., Ishida T., Nonomura Y., Kono Y., Takahata R., Koh J., Sakai J., Takai A., Inada Y., Asaba H. Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. American Journal of Medical Genetics. 67:1996;103-105.
20. Kahn R.S., Wetzler S., van Praag H.M. Behavioral indications for receptor hypersensitivity in panic disorder. Psychiatry Research. 25:1988;101-104.
21. Kendler K.S., Neale M.C., Kessler R. Generalized anxiety disorder in women: a population-based twin study. Archives of General Psychiatry. 49:1992;267-272.
22. Kennedy J.L., Bradwejn J., Koszycki D., King N., Crowe R., Vincent J., Fourie O. Investigation of cholecystokinin system genes in panic disorder. Molecular Psychiatry. 4:1999;284-285.
23. Kobilka B.K., Frielle T., Collins S., Yang-Feng T., Kobilka T.S., Francke U., Lefkowitz R.J., Carrion M.G. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature. 329:1987;75-79.
24. Lappalainen J., Zhang L., Deam M., Ozaki N., Yu D.H., Virkkunen M., Weiht F., Linnoila M., Goldman D. Identification, expression and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). Genomics. 27:1995;274-279.
25. Lesch K.P., Wiesmann M., Hoa A., Müller T., Disselkamp T.J., Osterheider M., Schulte H.M. 5-HT1A receptor effector system responsivity in panic disorder. Psychopharmacology. 106:1992;111-117.
26. Nöthen M.M., Rietschel J., Erdmann J., Oberlander H., Moller H.J., Naber D., Propping P. Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet. 346:1995;908-909.
27. Noyes R.J., Crowe R.R., Harris E.L. Relationship between panic disorder and agoraphobia. A family study. Archives of General Psychiatry. 43:1986;227-232.
28. Quist J.F., Barr C.L., Schachar R., Roberts W., Malone M., Tannock R., Basile V.S., Beitchman J., Kennedy J.L. Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD). Molecular Psychiatry. 5:2000;537-541.
29. Saltzman A.G., Morse B., Whitman M.M., Ivanshchenko Y., Jaye M., Felder S. Cloning of the human serotonin 5-HT2 and 5HT1C receptor subtypes. Biochemical and Biophysical Research Communications. 181:1991;1469-1478.
30. Stein M.B., Chartier M.J., Kozak M.V., King N., Kennedy J.L. Genetic linkage to the serotonin transporter protein and 5HT2A receptor genes excluded in generalized social phobia. Psychiatry Research. 81:1998;283-291.
31. Torgersen S. Genetic factor in anxiety disorder. Archives of General Psychiatry. 40:1983;1085-1089.
32. Vieland V., Goodman D., Chapman T., Fyer A. New segregation analysis of panic disorder. American Journal of Medical Genetics. 67:1996;147-153.
33. Wang Z., Valdes J., Noyes R., Zoega T., Crowe R.R. Possible association of a cholecystokinin promoter polymorphism (CCK-36CT) with panic disorder. American Journal of Medical Genetics. 81:1998;228-234.
34. Warren J.T. Jr, Peacock M.L., Fink J.K. An RsaI polymorphism in the human serotonin receptor gene (HTR1A): detection by DGGE and RFLP analysis. Human Molecular Genetics. 1:1992;778.
35. Warren J.T. Jr, Peacock M.L., Rodrigues L.C., Fink J.K. An MspI polymorphism in the human serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Human Molecular Genetics. 2:1993;338.
36. Weissman M.M., Bland R.C., Canino G.J., Faravelli C., Greenwald S., Hwu H.G., Joyce P.R., Karam E.G., Lee C.K., Lellouch J., Lépine J.P., Newman S.C., Oakley Browne M.A., Rubio S.M., Wells J.E., Wickramaratne P.J., Wittchen H.U., Yeh E.K. The cross-national epidemiology of panic disorder. Archives of General Psychiatry. 54:1997;305-309.
37. William J., McGuffin P., Nöthen M., Owen M.J. Meta-analysis of association between the 5HT2a receptor T102C polymorphism and schizophrenia. EMSS Collaborative Group. Lancet. 349:1997;1221.